Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1995 3
1998 1
2000 2
2001 3
2002 1
2003 4
2004 3
2005 4
2006 3
2007 1
2008 1
2009 1
2010 4
2011 2
2012 6
2013 2
2014 6
2015 2
2016 2
2017 3
2018 5
2019 8
2020 6
2021 8
2022 5
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy.
Han H, Jain AD, Truica MI, Izquierdo-Ferrer J, Anker JF, Lysy B, Sagar V, Luan Y, Chalmers ZR, Unno K, Mok H, Vatapalli R, Yoo YA, Rodriguez Y, Kandela I, Parker JB, Chakravarti D, Mishra RK, Schiltz GE, Abdulkadir SA. Han H, et al. Among authors: abdulkadir sa. Cancer Cell. 2019 Nov 11;36(5):483-497.e15. doi: 10.1016/j.ccell.2019.10.001. Epub 2019 Oct 31. Cancer Cell. 2019. PMID: 31679823 Free PMC article.
Overcoming immunosuppression in bone metastases.
Reinstein ZZ, Pamarthy S, Sagar V, Costa R, Abdulkadir SA, Giles FJ, Carneiro BA. Reinstein ZZ, et al. Among authors: abdulkadir sa. Crit Rev Oncol Hematol. 2017 Sep;117:114-127. doi: 10.1016/j.critrevonc.2017.05.004. Epub 2017 May 12. Crit Rev Oncol Hematol. 2017. PMID: 28600175 Review.
Turning Up the Heat on MYC: Progress in Small-Molecule Inhibitors.
Truica MI, Burns MC, Han H, Abdulkadir SA. Truica MI, et al. Among authors: abdulkadir sa. Cancer Res. 2021 Jan 15;81(2):248-253. doi: 10.1158/0008-5472.CAN-20-2959. Epub 2020 Oct 21. Cancer Res. 2021. PMID: 33087323 Free PMC article. Review.
Emerging therapeutic targets in bladder cancer.
Carneiro BA, Meeks JJ, Kuzel TM, Scaranti M, Abdulkadir SA, Giles FJ. Carneiro BA, et al. Among authors: abdulkadir sa. Cancer Treat Rev. 2015 Feb;41(2):170-8. doi: 10.1016/j.ctrv.2014.11.003. Epub 2014 Nov 24. Cancer Treat Rev. 2015. PMID: 25498841 Review.
Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC.
Panja S, Truica MI, Yu CY, Saggurthi V, Craige MW, Whitehead K, Tuiche MV, Al-Saadi A, Vyas R, Ganesan S, Gohel S, Coffman F, Parrott JS, Quan S, Jha S, Kim I, Schaeffer E, Kothari V, Abdulkadir SA, Mitrofanova A. Panja S, et al. Among authors: abdulkadir sa. Nat Commun. 2024 Jan 8;15(1):352. doi: 10.1038/s41467-024-44686-5. Nat Commun. 2024. PMID: 38191557 Free PMC article.
'Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting.
Gupta DG, Varma N, Sreedharanunni S, Abdulkadir SA, Naseem S, Sachdeva MUS, Binota J, Bose P, Malhotra P, Khadwal A, Varma S. Gupta DG, et al. Among authors: abdulkadir sa. Br J Cancer. 2023 Jul;129(1):143-152. doi: 10.1038/s41416-023-02294-y. Epub 2023 May 8. Br J Cancer. 2023. PMID: 37156894
81 results